Urinary angiotensinogen level is correlated with blood pressure level and proteinuria in patients with masked hypertension

References

• Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-spesific relevance of usual blood pressure to vascular mortalitiy: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903–13.
   PubMed Web of Science ®Google Scholar
• Ruilope LM, Rodicio JL. Clinical relevance of proteinuria and microalbuminuria. Curr Opin Nephrol Hypertens 1993;2:962–67.
   PubMedGoogle Scholar
• Schmieder RE, Mann JF, Schumacher H. Changes in albuminuria predict mortality and morbidity in patients with vascular disease. J Am Soc Nephrol 2011;22:1353–64.
   PubMed Web of Science ®Google Scholar
• Kunz R, Friedrich C, Wolbers M, Mann JF. Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease. Ann Intern Med 2008;148:30–48.
   PubMed Web of Science ®Google Scholar
• Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 2006;47:846–53.
   PubMed Web of Science ®Google Scholar
• Bobrie G, Chatellier G, Genes N. Cardiovascular prognosis of “masked hypertension”detected by blood-pressure self-measurement in elderly treated hypertensive patients. Jama 2004;291:1342–49.
   PubMed Web of Science ®Google Scholar
• Fagard RH, Cornelissen VA. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens 2007;25:2193–98.
   PubMed Web of Science ®Google Scholar
• Leltao CB, Canani LH, Kramer CK, Boza JC, Pinotti AF, Gross JL. Masked hypertension, urinary albumin exration rate and echocardigraphic parameters in putatively normotensive type2 diabetes mellitus. Daibetes Care 2007;30:1255–60.
   PubMed Web of Science ®Google Scholar
• Agarwal R. Albuminuria and masked uncontrolled hypertension in chronic kidney disease. Nephrol Dial Transplant 2016;1–7.
   PubMed Web of Science ®Google Scholar
• Bader M, Ganten D. Update on tissue renin-angiotensin systems. J Mol Med 2008;86:615–21.
   PubMed Web of Science ®Google Scholar
• Velez JC. The importance of the intrarenal renin-angiotensin system. Nat Clin Pract 2009;5:89–100.
   Google Scholar
• Kobori H, Harrison-Bernard LM, Navar LG. Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production. Kidney Int 2002;61:579–85.
   PubMed Web of Science ®Google Scholar
• Kobori H, Alper AB Jr, Shenava R. Urinary angiotensinogen as a novel biomarker of the intrarenal renin-angiotensin system status in hypertensive patients. Hypertensin 2009;53:344–50.
   PubMed Web of Science ®Google Scholar
• Liu F, Brezniceanu ML, Wei CC. Overexpression of angiotensinogen increases tubuler apoptosis in diabetes. J Am Soc Nephrol 2008;19:269–80.
   PubMed Web of Science ®Google Scholar
• Kobori H, Ohashi N, Katsurada A. Urinary angiotensinogen as a potential biomarker of severity of chronic kidney disease. J Am Soc Hypertens 2008;2:349–54.
   PubMed Web of Science ®Google Scholar
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF. Turner TC: homestasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin consentrations in man. Diabetologia 1985;28:412–19.
   PubMed Web of Science ®Google Scholar
• Levey AS, Bosch JP, Lewis JB, Grene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study. Ann Intern Med 1999;130(6):461–70.
   PubMed Web of Science ®Google Scholar
• Saito T, Urushihara M, Kotani Y, Kotani Y, Kagami S, Kobori H. Increased urinary angiotensinogen is precedent to increased urinary albumin in patients with type 1 diabetes. Am J Med Sci 2009;338(6):478–80.
   PubMed Web of Science ®Google Scholar
• Nishiyama A, Konishi Y, Ohashi N. Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy. Nephrol Dial Transplant 2011;26:170–77.
   PubMed Web of Science ®Google Scholar
• Weir MR. Effects of renin-angiotensin system inhibitionend-organ protection: can we do beter? Clin Ther 2007;29(9):1803–24.
   PubMed Web of Science ®Google Scholar
• Navar LG, Prieto MC, Satou R, Kobori H. Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. Curr Opin Pharmacol 2011;11(2):180–86.
   PubMed Web of Science ®Google Scholar
• Franco M, Martinez F, Quiroz Y. Renal angiotensin II concentration and interstitial infiltration of ımmune cells are correlated with blood pressure levels in saltsensitive hypertension. Am J Physiol Regul Integr Comp Physiol 2007;293:R251–256.
   PubMed Web of Science ®Google Scholar
• Navar LG, Harrison-Bernard LM, Nishiyama A, Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 2002;39:316–22.
   PubMed Web of Science ®Google Scholar
• Dell’Italia LJ, Meng QC, Ballcells E. Compartmentalization of angiotensin II generation in the dog heart evidence for independent mechanisms in intravascular and interstitial spaces. J Clin Invest 1997;100:253–58.
   PubMed Web of Science ®Google Scholar
• Kobori H, Nishiyama A, Harrison-Bernard LM, Navar LG. Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension. Hypertension 2003;41:42–49.
   PubMed Web of Science ®Google Scholar
• Papadopoulos DP, Makris TK. Masked hypertension definition, impact, outcomes: a critical review. J Clin Hypertens 2007;9(12):956–63.
   Google Scholar
• Mallion JM, Clerson P, Bobrie G, Genes N, Vaisse B, Chatellier G. Predictive factors for masked hypertension within a population of controlled hypertensives. J Hypertens 2006;24:2365–70.
   PubMed Web of Science ®Google Scholar
• Cacciolati C, Hanon O, Alperovitch A, Dufouil C, Tzourio C. Masked hypertension in the elderly: cross-sectional analysis of a population-based sample. Am J Hypertens 2011;24:674–80.
   PubMed Web of Science ®Google Scholar
• Wang GL, Li Y, Staessen JA, Lu L, Wang JG. Anthropometric and lifestyle factors associated with white-coat, masked and sustained hypertension in a Chinese population. J Hypertens 2007;25:2398–405.
   PubMed Web of Science ®Google Scholar
• Mifsud SA, Allen TJ, Bertram JF. Podocyte foot pocess broadening in experimental diabetic nephropathy: amelioration with renin-angiotensin blockade. Diabetologia 2001;44(7):878–82.
   PubMed Web of Science ®Google Scholar
• Vieitez P, Gomez O, Uceda ER, Vera ME, Molina-Holgada E. Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy. J Renin Angiotensin Aldosterone Syst 2008;9:96–102.
   PubMed Web of Science ®Google Scholar
• Langham RG, Kelly DJ, Cox AJ. Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition. Diabetologia 2002;45:1572–76.
   PubMed Web of Science ®Google Scholar
• Charvat J, Chlumsky J, Szabo M, Zakovicova E, Zamrazil V. The association of masked hypertension in treated type 2 diabetic patients with carotid artery IMT. Diabetes Res Clin Pract 2010;89:239–42.
   PubMed Web of Science ®Google Scholar
• Agarwal R, Pappas MK, Sinha AD. Masked uncontrolled hypertension in CKD. J Am Soc Nephrol 2016;27(3):924–32.
   PubMed Web of Science ®Google Scholar